4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-076400
Options or other derivatives
- Director acquired 70,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2024-06-21 | Grant or award · Restricted Stock Units | +29,600 | 29,600 | D | ||
| Duncan Barbara Gayle Director | 2024-06-21 | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | D | ||
Loading xslF345X05/ownership.xml…